tert-butyl N-(3-hydroxy-3-methylcyclobutyl)carbamate

Catalog No.: 
ACMYPE856
CAS No.: 
1427329-27-8
Molecular Formula: 
C10H19NO3
Molecular Weight: 
201.27
tert-butyl N-(3-hydroxy-3-methylcyclobutyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$647.00InquiryInquiry
250mg95%$952.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl N-(3-hydroxy-3-methylcyclobutyl)carbamate
IUPAC Nametert-butyl (3-hydroxy-3-methylcyclobutyl)carbamate
MDL No.MFCD20926157
Molecular FormulaC10H19NO3
Molecular Weight201.27
SMILESO=C(OC(C)(C)C)NC1CC(C)(O)C1
InChI KeyMDBARZYXJRKEAH-UHFFFAOYSA-N
Synonymtert-butyl N-(3-hydroxy-3-methylcyclobutyl)carbamate;Carbamic acid, N-(3-hydroxy-3-methylcyclobutyl)-, 1,1-dimethylethyl ester;3-(Boc-amino)-1-methylcyclobutanol;tert-butyl (3-hydroxy-3-methylcyclobutyl)carbamate
CAS No.1427329-27-8

Synthetic Route by SureRoute

1. ACMYPE856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLDSE319 route compound structure diagram
    ACLDSE319154748-49-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMYPE856 route product structure diagram
    ACMYPE8561427329-27-8
Inquiry

2. ACMYPE856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTVXS592 route compound structure diagram
    ACTVXS5921502504-47-3In Stock
  4. Then
  5. ACMYPE856 route product structure diagram
    ACMYPE8561427329-27-8
Inquiry

3. ACMYPE856 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLDSE319 route compound structure diagram
    ACLDSE319154748-49-9In Stock
  4. Then
  5. ACMYPE856 route product structure diagram
    ACMYPE8561427329-27-8
Inquiry

Comments (0)